[{"address1": "451 D Street", "address2": "5th Floor Suite 501", "city": "Boston", "state": "MA", "zip": "02210", "country": "United States", "phone": "857 209 0050", "website": "https://elicio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops a pipeline of novel immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node\u0096targeted AMP peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company is also developing ELI-007, a multivalent lymph node\u0096targeted AMP peptide vaccine to target mutant v-raf murine sarcoma viral oncogene homolog B1 gene mutations found in solid tumors; and ELI-008, a multivalent lymph node\u0096targeted AMP peptide vaccine to target p53 hotspot mutations. The company is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert T. Connelly", "age": 64, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 943020, "exercisedValue": 0, "unexercisedValue": 137562}, {"maxAge": 1, "name": "Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.", "age": 77, "title": "Founder & Independent Director", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 48125, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  DeMuth Ph.D.", "age": 37, "title": "Chief Scientific Officer", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 648600, "exercisedValue": 0, "unexercisedValue": 54705}, {"maxAge": 1, "name": "Dr. Christopher M. Haqq M.D., Ph.D.", "age": 58, "title": "Executive VP, Head of Research & Development and Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 721087, "exercisedValue": 0, "unexercisedValue": 86025}, {"maxAge": 1, "name": "Dr. Darrell J. Irvine Ph.D.", "title": "Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Preetam  Shah M.B.A., Ph.D.", "age": 51, "title": "Chief Strategy & Financial Officer and Treasurer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  DiVecchia", "title": "Senior Vice President of Operations & Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan C. Filoon", "title": "General Counsel, Secretary & Compliance Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Esther  Welkowsky", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Joy  Seymour", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.07, "open": 5.25, "dayLow": 5.125, "dayHigh": 5.74, "regularMarketPreviousClose": 5.07, "regularMarketOpen": 5.25, "regularMarketDayLow": 5.125, "regularMarketDayHigh": 5.74, "payoutRatio": 0.0, "forwardPE": -1.996109, "volume": 37919, "regularMarketVolume": 37919, "averageVolume": 47379, "averageVolume10days": 40110, "averageDailyVolume10Day": 40110, "bid": 5.35, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 81841456, "fiftyTwoWeekLow": 3.342, "fiftyTwoWeekHigh": 11.45, "fiftyDayAverage": 6.9687, "twoHundredDayAverage": 5.667005, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 90189424, "profitMargins": 0.0, "floatShares": 10268426, "sharesOutstanding": 15953500, "sharesShort": 151823, "sharesShortPriorMonth": 170043, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0095, "heldPercentInsiders": 0.43480998, "heldPercentInstitutions": 0.07116, "shortRatio": 3.19, "shortPercentOfFloat": 0.0148, "impliedSharesOutstanding": 15953500, "bookValue": -1.026, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -51898000, "trailingEps": -4.25, "forwardEps": -2.57, "lastSplitFactor": "1:10", "lastSplitDate": 1685664000, "enterpriseToEbitda": -2.019, "52WeekChange": -0.43626374, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 5.13, "targetHighPrice": 12.0, "targetLowPrice": 10.0, "targetMeanPrice": 11.0, "targetMedianPrice": 11.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 17618000, "totalCashPerShare": 1.105, "ebitda": -44665000, "totalDebt": 26040000, "quickRatio": 1.529, "currentRatio": 1.796, "returnOnAssets": -1.01642, "returnOnEquity": -1701.5737, "freeCashflow": -23701624, "operatingCashflow": -37068000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ELTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Elicio Therapeutics, Inc.", "longName": "Elicio Therapeutics, Inc.", "postMarketChangePercent": 0.0, "postMarketPrice": 5.13, "postMarketChange": 0.0, "regularMarketChange": 0.059999943, "regularMarketDayRange": "5.125 - 5.74", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 47379, "fiftyTwoWeekLowChange": 1.7880001, "fiftyTwoWeekLowChangePercent": 0.535009, "fiftyTwoWeekRange": "3.342 - 11.45", "fiftyTwoWeekHighChange": -6.3199997, "fiftyTwoWeekHighChangePercent": -0.55196506, "fiftyTwoWeekChangePercent": -43.626373, "earningsTimestamp": 1743418800, "earningsTimestampStart": 1747133940, "earningsTimestampEnd": 1747656000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.25, "epsForward": -2.57, "epsCurrentYear": -2.4, "priceEpsCurrentYear": -2.1375, "fiftyDayAverageChange": -1.8386998, "fiftyDayAverageChangePercent": -0.2638512, "twoHundredDayAverageChange": -0.53700495, "twoHundredDayAverageChangePercent": -0.09475992, "priceToBook": -5.0, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Angion Biomedica Corp.", "nameChangeDate": "2025-04-25", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "corporateActions": [], "postMarketTime": 1745611507, "regularMarketTime": 1745611202, "exchange": "NCM", "messageBoardId": "finmb_214936128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.1834308, "regularMarketPrice": 5.13, "displayName": "Elicio Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]